BioLineRx (BLRX) Income After Tax (2010 - 2026)
BioLineRx (BLRX) posted Profit After Tax of -$3.23 million for the quarter ended Jun 30, 2026, compared with -$1.54 million a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) Income After Tax (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Profit After Tax at BioLineRx was -$10.11 million; for the year ended Dec 31, 2025, it came in at -$7.54 million.
- In prior years, BioLineRx's Profit After Tax was -$9.42 million in the year ended Dec 31, 2024, -$45.46 million in the year ended Dec 31, 2023, -$26.31 million in the year ended Dec 31, 2022 and -$23.21 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Profit After Tax since the quarter ended Sep 30, 2024.
- According to Business Quant data, Profit After Tax for the three prior quarters was -$2.55 million (quarter ended Mar 31, 2026), -$2.8 million (quarter ended Dec 31, 2025) and -$1.53 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.25 Bn |
| 10 | BioLineRx | 6.74 Mn | -69.78 Mn | 235,000.00 | -3.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.65 Mn |
| Mar 31, 2026 | -2.55 Mn |
| Dec 31, 2025 | -5.36 Mn |
| Sep 30, 2025 | -1.53 Mn |
| Jun 30, 2025 | -2.09 Mn |
| Mar 31, 2025 | -1.68 Mn |
| Dec 31, 2024 | -17.85 Mn |
| Sep 30, 2024 | -3.33 Mn |
| Jun 30, 2024 | -7.32 Mn |
| Mar 31, 2024 | -3.33 Mn |
| Dec 31, 2023 | -23.06 Mn |
| Sep 30, 2023 | -11.21 Mn |
| Jun 30, 2023 | -10.81 Mn |
| Mar 31, 2023 | -7.39 Mn |
| Dec 31, 2022 | -10.95 Mn |
| Sep 30, 2022 | -6.70 Mn |
| Jun 30, 2022 | -7.90 Mn |
| Mar 31, 2022 | -5.83 Mn |
| Dec 31, 2021 | -8.15 Mn |
| Sep 30, 2021 | -5.90 Mn |
API Access
BioLineRx Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();